The New York Times
Emerging Coronavirus Variants May Pose Challenges to Vaccines
Laboratory studies from Michel Nussenzweig and others of mutations circulating in South Africa suggest they may dodge some of the body’s immune responses.
The Wall Street Journal
Companies Race to Develop Drugs That Stay Ahead of Coronavirus Mutations
Researchers are working on new antibody drugs that can be given with quick jabs in the arm, similar to flu shots. They would enable patients to get treated quickly after being diagnosed with Covid-19, said Michel C. Nussenzweig, an immunologist and professor at Rockefeller University in New York.
Nature News
Rogue Antibodies Could Be Driving Severe COVID-19
Evidence from Jean-Laurent Casanova and others is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.